Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update
On February 11, Citi analyst Joanne Wuensch lifted her price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $198 from $185.70 and maintained a Buy rating.
Becton Dickinson & Co (BDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 14,813,712 | $2,260,139,284 | +17% | 3.98% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,853,192.064 | $282,742,910 | +44009% | 0.26% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,068,294.288 | $162,990,466 | +127% | 0.1% |
| 4. | Diamond Hill Capital Ric Dillon | 194,540.952 | $29,681,260 | -2% | 0.15% |
| 5. | Levin Capital Strategies John A. Levin | 110,003.832 | $16,783,361 | +130% | 1.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $191.57 | 5,250 | $1,005,742.50 | 6,046 | 2025-08-11 | Filing | |
| $233.62 | 1,500 | $350,430.00 | 8,015 | 2025-02-10 | Filing | |
| $247.96 | 30 | $7,438.80 | 10,052 | 2019-04-16 | Filing | |
| $239.01 | 45 | $10,755.45 | 10,022 | 2018-06-22 | Filing | |
| $225.89 | 285 | $64,378.65 | 9,977 | 2018-04-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $202.73 | 75 | $15,204.75 | 16,431 | 2026-01-26 | Filing | |
| $206.54 | 1,010 | $208,605.40 | 12,095 | 2026-01-15 | Filing | |
| $209.00 | 600 | $125,400.00 | 13,105 | 2026-01-15 | Filing | |
| $196.08 | 74 | $14,509.92 | 16,506 | 2025-12-26 | Filing | |
| $196.03 | 629 | $123,302.87 | 13,105 | 2025-12-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 46,655,610.408 | $7,118,281,692 | 0.1% | |
| 2. | 35,169,152.76 | $5,365,784,238 | 0.09% | |
| 3. | 17,794,175.904 | $2,714,870,847 | 0.09% | |
| 4. | 12,067,074.768 | $1,841,082,704 | 0.59% | |
| 5. | 8,758,179.192 | $1,331,164,666 | 0.08% |
News See All
13 Cheapest Dividend Aristocrats to Invest in
Dividend stocks have lagged the broader market recently. However, there are hints that this stretch of underperformance may be losing momentum.
Becton, Dickinson and Company (NYSE:BDX) Q1 2026 Earnings Call Transcript
Operator: To all sites on hold, we would like to thank you for your patience. Please continue to stand by. To all sites on hold, we would like to thank you for your patience.
Jim Cramer’s Game Plan: 19 Stocks in Focus
I don't usually start the game plan on Wednesday, but that's when we get the employment report this time, and it's kind of screwed up because of the government shutdown.
Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX)
On January 28, Piper Sandler analyst Jason Bednar lifted Becton, Dickinson and Company (NYSE:BDX)’s price recommendation to $205 from $190. The analyst maintained a Neutral rating.
Becton, Dickinson and Company (BDX): A Bull Case Theory
We came across a bullish thesis on Becton, Dickinson and Company on Value Don't Lie’s Substack. In this article, we will summarize the bulls’ thesis on BDX.
Dividend Growth Stocks: 25 Aristocrats
Dividend aristocrats are companies that have raised their dividends every year for at least 25 years.
RBC Sees Durable Growth Profile at Becton Dickinson (BDX), Raises Target
On December 17, RBC Capital raised its price target on Becton, Dickinson and Company (NYSE:BDX) to $210 from $202 and kept a Sector Perform rating on the shares.
12 Best Income Stocks to Buy Now
Dividends have always played a meaningful role in market returns.
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector
On December 2, Morgan Stanley analyst Patrick Wood lifted the firm’s price target on Becton, Dickinson and Company (NYSE:BDX) to $210 from $197 and maintained an Overweight rating on the shares.
Hedge Fund Resource Center Billionaire Hedge Funds
